Sphera Funds Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Sphera Funds Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-116,000	Closed	-$9.23M	–	109
2019 Q2	$9.23M	Buy	116,000 +16,000	+16%	+$1.43M	1.26%	21
2019 Q1	$11.2M	Buy	+100,000	New	+$10.9M	1.02%	19
2017 Q3	–	Sell	-30,000	Closed	-$3.63M	–	152
2017 Q2	$3.63M	Buy	30,000 +15,000	+100%	+$1.74M	0.62%	49
2017 Q1	$1.7M	Buy	+15,000	New	+$1.75M	0.33%	77
2015 Q4	–	Sell	-17,500	Closed	-$2.9M	–	140
2015 Q3	$2.9M	Hold	17,500	–	–	0.37%	64
2015 Q2	$4.22M	Buy	17,500 +2,500	+17%	+$666K	0.41%	54
2015 Q1	$4.23M	Buy	15,000 +5,000	+50%	+$1.08M	0.44%	57
2014 Q4	$1.56M	Sell	10,000 -4,565	-31%	-$843K	0.27%	96
2014 Q3	$3.45M	Buy	+14,565	New	+$3.71M	0.43%	54

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sphera Funds Management's ICPT Position: Q3 2019 in Review

Sphera Funds Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2019, closing a stake of 116,000 shares — an estimated $9.23M sold.

Sphera Funds Management first reported a position in ICPT in Q3 2014 and held it in 9 quarters. The position peaked at $11.2M in Q1 2019. 188 funds tracked by Wall St. Rank hold ICPT as of Q3 2019.

Sphera Funds Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Sphera Funds Management sold 116,000 Intercept Pharmaceuticals, Inc. shares in Q3 2019, an estimated $9.23M.
Sphera Funds Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 9 quarters.
Sphera Funds Management's Intercept Pharmaceuticals, Inc. position peaked at $11.2M in Q1 2019.
188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2019.

Based on Sphera Funds Management's 13F filing for Q3 2019, filed 14 Nov 2019.